Shares of Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) were down 7.7% during mid-day trading on Friday. The stock traded as low as $3.46 and last traded at $3.46. Approximately 5,547 shares were traded during mid-day trading, an increase of 230% from the average session volume of 1,681 shares. The stock had previously closed at $3.75.
Ascentage Pharma Group International Stock Down 7.7%
The stock has a fifty day simple moving average of $4.20 and a two-hundred day simple moving average of $6.12.
About Ascentage Pharma Group International
Ascentage Pharma Group International is a biopharmaceutical company focused on discovering and developing small-molecule therapies for cancer and other serious diseases. The company’s research is centered on restoring programmed cell death, or apoptosis, by targeting proteins that help cancer cells survive, including members of the BCL-2 family, inhibitor of apoptosis proteins and the MDM2-p53 pathway.
Its investigational portfolio includes lisaftoclax (APG-2575), a BCL-2 inhibitor being studied in hematologic malignancies, and alrizomadlin (APG-115), an MDM2-p53 inhibitor being evaluated in oncology programs.
Read More
- Five stocks we like better than Ascentage Pharma Group International
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
